DFSVX
Price
$44.18
Change
-$0.03 (-0.07%)
Updated
May 22 closing price
Net Assets
14.59B
HSMAX
Price
$11.33
Change
+$0.03 (+0.27%)
Updated
May 22 closing price
Net Assets
172.3M
Interact to see
Advertisement

DFSVX vs HSMAX

Header iconDFSVX vs HSMAX Comparison
Open Charts DFSVX vs HSMAXBanner chart's image
DFA US Small Cap Value I
Price$44.18
Change-$0.03 (-0.07%)
VolumeN/A
Net Assets14.59B
Hartford Small Cap Value A
Price$11.33
Change+$0.03 (+0.27%)
VolumeN/A
Net Assets172.3M
DFSVX vs HSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFSVX vs. HSMAX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a Buy and HSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 14.6B vs. HSMAX (172M). DFSVX pays higher dividends than HSMAX: DFSVX (1.75) vs HSMAX (1.53). DFSVX was incepted earlier than HSMAX: DFSVX (32 years) vs HSMAX (20 years). HSMAX (1.33) is less costly to investors than DFSVX (0.31). HSMAX is a more actively managed with annual turnover of: 46.00 vs. DFSVX (12.00). DFSVX has a lower initial minimum investment than HSMAX: DFSVX (0) vs HSMAX (2000). HSMAX annual gain was more profitable for investors over the last year : -3.05 vs. DFSVX (-4.37). DFSVX return over 5 years is better than : 95.13 vs. HSMAX (73.60).
DFSVXHSMAXDFSVX / HSMAX
Total Expense Ratio0.311.3124%
Annual Report Gross Expense Ratio0.311.3323%
Fund Existence32 years20 years-
Gain YTD-8.511-7.965107%
Front LoadN/A6%-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets14.6B172M8,488%
Annual Yield % from dividends1.751.53114%
Returns for 1 year-4.37-3.05143%
Returns for 3 years14.438.45171%
Returns for 5 years95.1373.60129%
Returns for 10 years28.70-6.90-416%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMRN58.48-1.45
-2.42%
BioMarin Pharmaceutical
TALK2.90-0.09
-3.17%
Talkspace
IMVT14.41-0.59
-3.93%
Immunovant
PRPH0.29-0.04
-12.42%
ProPhase Labs
PTPI0.07-0.06
-46.45%
Petros Pharmaceuticals Inc